Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease

AbstractPurpose of ReviewLymphatic disorders have received an increasing amount of attention over the last decade. Sparked primarily by improved imaging modalities and the dawn of lymphatic interventions, understanding, diagnostics, and treatment of lymphatic complications have undergone considerable improvements. Thus, the current review aims to summarize understanding, diagnostics, and treatment of lymphatic complications in individuals with congenital heart disease.Recent FindingsThe altered hemodynamics of individuals with congenital heart disease has been found to profoundly affect morphology and function of the lymphatic system, rendering this population especially prone to the development of lymphatic complications such as chylous and serous effusions, protein-losing enteropathy and plastic bronchitis.SummaryAlthough improved, a full understanding of the pathophysiology and targeted treatment for lymphatic complications is still wanting. Future research into pharmacological improvement of lymphatic function and continued implementation of lymphatic imaging and interventions may improve knowledge, treatment options, and outcome for affected individuals.
Source: Current Cardiology Reports - Category: Cardiology Source Type: research

Related Links:

We report the case of a 5-year-old boy who developed chronic plastic bronchitis after Fontan surgery for a complex congenital heart disease. During a new admission for acute exacerbation of plastic bronchitis, he started on a mucolytic treatment with inhaled rhDNAse instead of inhaled fibrinolytics because of the potential bleeding risk in a patient on combined coumarin and aspirin treatment. Respiratory symptoms resolved promptly, and the patient was discharged home on rhDNAse treatment. He remained clinically stable on rhDNAse treatment without further hospitalization until definitive treatment with dynamic lymphangiogra...
Source: Pediatric Cardiology - Category: Cardiology Source Type: research
(Natural News) COPD, or chronic obstructive pulmonary disease, is an umbrella term referring to a group of progressive lung diseases. Among the common diseases classified under COPD are emphysema and chronic bronchitis. According to the American Lung Association, COPD is the third leading cause of death in the US, only behind cancer and heart disease....
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
(Natural News) Chronic obstructive pulmonary disease (COPD) refers to a group of progressive lung diseases, including common ones like emphysema and chronic bronchitis. According to the American Lung Association, COPD is the third leading cause of death in the US, behind cancer and heart disease. More than 15.3 million Americans have been diagnosed with COPD,...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
Publication date: January 2020Source: Archives of Cardiovascular Diseases Supplements, Volume 12, Issue 1Author(s): A. Bah, Z. El Abasse, A. Drighil, R. HabbalIntroductionCongenital mitral stenosis is defined as any obstacle to diastolic filling of the left ventricle due to abnormal development of the structures that form the mitral apparatus (ring, immediately supravalvular area, cords and pillars). It is a rare congenital malformation, its prevalence is estimated at 4 in 1000 children diagnosed with congenital heart disease and it constitutes 0.6 to 1.2% of autopsied congenital heart defects.ObjectiveClinical,epidem...
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research
Dyspnea is the most important respiratory symptom. Objectivization of its severity is an important evaluation parameter of health condition.Objective: to evaluate the prevalence of respiratory symptoms in the rural population.Results: completed questionnaires 3621 resident, including the 1505 primary health care (PHC) based patients, and 2116 household based patients, living on the territory of the settlements included in the research. The age of the respondents is 53.7 ±1.0 years for PHC based patients and 49.9 ±1.6 years for household based patients. Male is accounted for 31.5% and 34.4% respectively in bot...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Epidemiology Source Type: research
Background: Physical activity and decreased skeletal muscle strength are related to dyspnea, exacerbations, hospitalizations and mortality in COPD. The aim of our study was to assess the relationship between muscle strength in the upper limbs with the survival prognosis in COPD patients measured by BODE index and create the BODH index (BMI, Obstruction, Dyspnea, Handgrip) if the main objective of the study was demonstrated.Method: We included stable COPD patients attended to our clinic, studying clinical and demographic variables, exacerbations, BODE and BODEx index, lung function, GesEPOC classification and strength in up...
Source: European Respiratory Journal - Category: Respiratory Medicine Authors: Tags: Monitoring airway disease Source Type: research
By Mark HurleyWASHINGTON DC, Oct 23 2019 (IPS) New information published in the Morbidity and Mortality Weekly Report shows that action taken by just 11 countries – most of them low- or middle-income – has resulted in 20 million fewer adult tobacco users in 2017 compared with 2008. Seventy percent of the world’s tobacco users live in low- and middle-income countries. This promising progress is a testament to strong government action and its effects are far reaching. Between 2008 and 2017, over 53 million fewer adults were exposed to secondhand smoke in indoor public places like restaurants, government bu...
Source: IPS Inter Press Service - Health - Category: International Medicine & Public Health Authors: Tags: Development & Aid Editors' Choice Featured Global Global Governance Headlines Health Inequity IPS UN: Inside the Glasshouse Poverty & SDGs TerraViva United Nations Source Type: news
(WASHINGTON) — For the first time, U.S. health regulators have endorsed a brand of tobacco pouches as less harmful than cigarettes, a decision that could open the door to other less risky options for smokers. The milestone announcement on Tuesday from the Food and Drug Administration marks the government’s first backing of a so-called “reduced risk” tobacco product. FDA regulators stressed, though, that the Swedish Match pouches are not safe, just less harmful, and that all tobacco products pose risks. The pouches will still bear mandatory government warnings that they can cause mouth cancer, gum di...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized FDA onetime Smoking Source Type: news
ConclusionExperiments show that the prognostic effect of the recurrent attention model is significantly higher than that of other traditional machine learning models. Because the model increases the attention mechanism, the important features affecting the prognostic results are obtained, which enables doctors to prescribe drugs according to the symptoms, take timely precautions and help patients to treat in time.Graphical abstract
Source: IRBM - Category: Biomedical Engineering Source Type: research
A major U.S. tobacco company on Saturday issued a press release boasting that smoking its cigarettes is no more harmful than vaping an e-cigarette that contains no tobacco and involves no combustion, at least in terms of lung disease. A spokesperson for the company was kind enough to allowThe Rest of the Story to interview him. The transcript appears below, with only slight editing for purposes of clarity. I was given permission to publish the interview, but under the condition that I not name the spokesperson.The Rest of the Story: Let me first make sure I have this correctly. You are saying that in terms of lung disease,...
Source: The Rest of the Story: Tobacco News Analysis and Commentary - Category: Addiction Source Type: blogs
More News: Bronchitis | Cardiology | Heart | Heart Disease